pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,879 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area
    • Infectious Disease3

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06272812: A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region.

    Sponsor: International AIDS Vaccine Initiative. Phase: PHASE2. Conditions: Tuberculosis (TB)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07215312: A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin

    Sponsor: Eli Lilly and Company. Phase: PHASE2. Conditions: Diabetes Mellitus, Type 2

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07290881: Comparing the Postoperative Analgesic Efficacy of Anterior Iliac Block and Ilioinguinal-iliohypogastric Block in Inguinal Hernia Surgery

    Sponsor: Harran University. Phase: NA. Conditions: Acute Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06149819: Chest Pain Nurse Track

    Sponsor: University Hospital, Grenoble. Phase: NA. Conditions: Chest Pain

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT05170828: Cryopreserved MMUD BM With PTCy for Hematologic Malignancies

    Sponsor: Ossium Health, Inc.. Phase: PHASE1. Conditions: Acute Leukemia, Myelodysplastic Syndromes, T-lymphoblastic Lymphoma, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic Leukemia, Acute Undifferentiated Leukemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02574728: Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

    Sponsor: Emory University. Phase: PHASE2. Conditions: Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06024928: Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes

    Sponsor: University of Virginia. Phase: NA. Conditions: Type 2 Diabetes

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07466771: Art Education and Creativity in Midwifery Students

    Sponsor: Selcuk University. Phase: NA. Conditions: Creativity and Mindfulness

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05040971: Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes

    Sponsor: Novo Nordisk A/S. Phase: PHASE3. Conditions: Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06027671: Structured Peer-delivered ART and Reentry Community Strategy

    Sponsor: Johns Hopkins University. Phase: NA. Conditions: Retention in Care

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06747871: Opioids, Low Nicotine Cigarettes, and Chronic Pain

    Sponsor: Duke University. Phase: NA. Conditions: Chronic Pain, Tobacco Use, Opioid Substitution Treatment

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03490071: Long-term Follow up of Patients With Longstanding Hip and Groin Pain

    Sponsor: Lund University. Phase: . Conditions: Hip Pain Chronic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07185971: PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic Brain Injury, or Brain Surgery

    Sponsor: NeuroAEye LLC. Phase: NA. Conditions: Homonymous Hemianopsia, Homonymous Quadrantanopia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06886971: Strategies to AchieVe Viral Suppression for Youth With HIV

    Sponsor: Johns Hopkins University. Phase: NA. Conditions: Human Immunodeficiency Virus (HIV) Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07559071: Effects of Emotional Freedom Technique and Music Therapy in High-Risk Pregnancy

    Sponsor: Selcuk University. Phase: NA. Conditions: Preterm Premature Rupture of Membranes (PPROM), Premature Rupture of Membranes (PROM), High-Risk Pregnancy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07390344: VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)

    Sponsor: W.L.Gore & Associates. Phase: . Conditions: Ascites, Variceal Bleeding, Portal Hypertension Related to Cirrhosis

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT02579044: Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria

    Sponsor: Boston Children's Hospital. Phase: PHASE1. Conditions: Progeria

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07435909: Bupivacaine for Postoperative Pain After Laparoscopic Hysterectomy

    Sponsor: Serkan Kumbasar. Phase: NA. Conditions: Postoperative Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07396909: A First-in-Human Single and Multiple Ascending Dose Study of MT-701

    Sponsor: Mirador Therapeutics, Inc.. Phase: PHASE1. Conditions: Healthy Volunteers

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00001532: Role of Genetic Factors in the Development of Lung Disease

    Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Cystic Fibrosis, Pulmonary Fibrosis, Tuberous Sclerosis, Asthma, Pulmonary Sarcoidosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03645863: Effects of Iron Supplements on the Pharmacokinetics of MT-6548

    Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Healthy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07447063: The Impact of Dietary Salt on the Severity of Eczema

    Sponsor: University of California, San Francisco. Phase: PHASE4. Conditions: Eczema, Atopic Dermatitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07460687: Westlake Frequent-sampling Cohort

    Sponsor: Westlake University. Phase: . Conditions: Health Adults, Stability of Microbiome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06999187: A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

    Sponsor: Dren Bio. Phase: PHASE1. Conditions: Triple Negative Breast Cancer, HER2-negative Breast Cancer, Non Small Cell Lung Cancer, Cervical Cancer, Castrate Resistant Prostate Cancer, Pancreatic Ductal Adenocarcinoma, Head-and-neck Squamous Cell Carcinoma, Endometrial Cancer, Ovarian Cancer, Gastric Cancer, Gastroesophageal-junction Cancer, Urothelial Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07474987: Portable VR-based Chromatic Pupilloperimeter for Diagnosis and Monitoring of Traumatic Brain Injury

    Sponsor: Sheba Medical Center. Phase: . Conditions: Traumatic Brain Injury (TBI) Patients, Healthy Participants, Non-TBI Trauma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06918587: A Comparative Evaluation of Pharmacokinetics and Immunogenicity.

    Sponsor: Kashiv BioSciences, LLC. Phase: PHASE1. Conditions: Febrile Neutropenia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07521787: Prognostic Value of Metabolic Characteristics in High-Risk Populations for Acute Kidney Injury After Cardiac Surgery

    Sponsor: Shanghai Zhongshan Hospital. Phase: . Conditions: Cardiac Surgery Associated - Acute Kidney Injury, Critical Illness

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05814666: Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC

    Sponsor: Flamingo Therapeutics NV. Phase: PHASE2. Conditions: HNSCC

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06561451: Live Birth Rate Between ICSI and AOA and ICSI Alone in Patients With Severe Teratospermia

    Sponsor: ShangHai Ji Ai Genetics & IVF Institute. Phase: NA. Conditions: Male Infertility, Teratospermia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02793453: Antimicrobial Peptides in Periodontitis

    Sponsor: CHU de Reims. Phase: NA. Conditions: Periodontal Disease : Chronic Periodontitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07302802: Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice

    Sponsor: Prof. Dr. Martin Wabitsch. Phase: . Conditions: Monogenic Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04984837: Study of Lacutamab in Peripheral T-cell Lymphoma

    Sponsor: The Lymphoma Academic Research Organisation. Phase: PHASE2. Conditions: Peripheral T Cell Lymphoma, Relapse/Recurrence

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06362837: Evaluation of REACTS-IN, an Intervention to Improve Nutrition, Hygiene, and Sexual and Reproductive Health Services

    Sponsor: McGill University. Phase: NA. Conditions: Stunting, Gender Equality, Acceptability of Health Care, Diet; Deficiency, Empowerment

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07444645: PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Tumor, Liver

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07495345: Feasibility Study of a Novel Automated Slit Lamp Camera (Lightfield Medical Ophthalmic Camera Model Vscan001)

    Sponsor: Lightfield Medical. Phase: NA. Conditions: Anterior Segment of Eye

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07203339: Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine: Non-inferiority Clinical Trial (FIBROSTIM)

    Sponsor: Hospital de Clinicas de Porto Alegre. Phase: NA. Conditions: Fibromyalgia (FM), tDCS, Duloxetine, BDNF, EEG

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04217239: A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy

    Sponsor: The Second Hospital of Shandong University. Phase: NA. Conditions: Esophageal Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06232577: 5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Intra-abdominal Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03520101: Comparison of the Balloon-Expandable Edwards Valve and Self-Expandable CoreValve Evolut R or Evolut PRO System for the Treatment of Small, Severely Dysfunctional Surgical Aortic Bioprotheses. The 'LYTEN' Trial

    Sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec. Phase: NA. Conditions: Aortic Valve Stenosis, Regurgitation, Aortic, Prosthesis Failure

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06618781: Perioperative Effects of Lateral Quadratus Lumborum Block in Percutaneous Transhepatic Cholangiography

    Sponsor: Ankara Etlik City Hospital. Phase: NA. Conditions: Opioid Consumption, Visual Analog Score, Demographic Data, Rescue Analgesic Status and Time

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07279181: TVS, SHG, and MRI in Uterine Niche

    Sponsor: International Peace Maternity and Child Health Hospital. Phase: . Conditions: Uterine Niche

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05708430: Tolerance of Intra-articular Injection Autologous Stromal Vascular Fraction for the Treatment of Rhizarthrosis

    Sponsor: University Hospital, Rouen. Phase: PHASE2. Conditions: Rhizarthrosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03166930: Evaluation of a Spasticity Management Program for People With Multiple Sclerosis

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Multiple Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06712628: A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING

    Sponsor: AbbVie. Phase: . Conditions: Moderate to Severe Rheumatoid Arthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07525765: AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer

    Sponsor: First Affiliated Hospital of Zhejiang University. Phase: . Conditions: Gastrectomy for Gastric Cancer, Gastric Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06409065: Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07032571: Reset: Enhancing Weight Loss in a Digital Intervention

    Sponsor: Stanford University. Phase: NA. Conditions: Obesity, Overweight, Weight Loss, Health Behavior, Lifestyle Intervention

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07343271: Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and Oropharynx

    Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07364071: Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer

    Sponsor: University of California, San Diego. Phase: PHASE2. Conditions: Prostate Adenocarcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05892744: Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression

    Sponsor: University of Texas at Austin. Phase: PHASE4. Conditions: Major Depressive Disorder, Chronic Major Depression, Recurrent

    full page →ctgov ↗
    ← prev
    page 19 of 98
    next →